HORIZON-MISS-2024-CANCER-01-03
HORIZON-MISS-2024-CANCER-01-03
Programme: Horizon Europe
3 projects · €37,251,795 total EU contribution (project-level) · 77 participating organizations · 24 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€37,251,795
Countries active
Participant organizations by country (headquarters in CORDIS).
- EL (14)
- France (6)
- SE (6)
- BE (5)
- UK (5)
- CZ (4)
- Spain (4)
- PT (4)
- CY (3)
- Germany (3)
- Italy (3)
- LT (3)
- NO (3)
- CH (2)
- Netherlands (2)
- SI (2)
- CA (1)
- DK (1)
- FI (1)
- HR (1)
- IE (1)
- LU (1)
- LV (1)
- SK (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- EVITA2 projects · PT
- HELLENIC CANCER FEDERATION2 projects · EL
- UNRF2 projects · CY
- RESEARCH UNIVERSITY INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS2 projects · EL
- UOA2 projects · EL
- THE CYPRUS FOUNDATION FOR MUSCULAR DYSTROPHY RESEARCH CYRUS INSTIT OF NEURO & GENETICS2 projects · CY
- 1ST YPE ATTICA1 projects · EL
- AINIGMA1 projects · BE
- ANADELTA TECHNOLOGIES IKE1 projects · EL
- BRAINS INNOVATIVE CONSULTING SERVICES1 projects · EL
- Cancerföreningen PALEMA1 projects · SE
- CARE ACROSS LTD1 projects · UK
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Disarming the silent threat of ovarian cancer DISARM · 101214318 | HORIZON | €11,999,087 | €400,000 | Details |
Comprehensive Surveillance of High-risk Individuals and Health Integration for Early detection of Pancreatic cancer utilising innovative multiplex immunoassays SHIELD · 101214779 | HORIZON | €11,646,388 | €0 | Details |
Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome PREDI-LYNCH · 101213916 | HORIZON | €13,606,320 | €158,600 | Details |